[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663–676.
[2] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131(5): 861–872.
[3] Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318(5858): 1917–1920.
[4] Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovas-cular and hematopoietic lineages. Stem Cells, 2008, 26(6): 1537–1546.
[5] Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and sub-sequent excision of reprogramming factors. Nature, 2009, 458(7239): 771–775.
[6] Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458(7239): 766–770.
[7] Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136(5): 964–977.
[8] Liu HS, Zhu FF, Yong J, Zhang PB, Hou PP, Li HG, Jiang W, Cai J, Liu M, Cui K, Qu XX, Xiang TT, Lu DY, Chi XC, Gao G, Ji WZ, Ding MX, Deng HK. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell, 2008, 3(6): 587–590.
[9] Li WL, Wei W, Zhu SY, Zhu JL, Shi Y, Lin TX, Hao EG, Hayek A, Deng HK, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic re-programming and chemical inhibitors. Cell Stem Cell, 2009, 4(1): 16–19.
[10] Wu Z, Chen JJ, Ren JT, Bao L, Liao J, Cui C, Rao LJ, Li H, Gu YJ, Dai HM, Zhu H, Teng XK, Cheng L, Xiao L. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol, 2009, 1(1): 46–54.
[11] Esteban MA, Xu JY, Yang JY, Peng MX, Qin DJ, Li W, Jiang ZX, Chen JK, Deng K, Zhong M, Cai JL, Lai LX, Pei DQ. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem, 2009, 284(26): 17634–17640.
[12] Li CL, Yu HY, Ma Y, Shi GL, Jiang J, Gu JJ, Yang Y, Jin SB, Wei Z, Jiang H, Li JS, Jin Y. Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One, 2009, 4(8): e6724.
[13] Li CL, Zhou JM, Shi GL, Ma Y, Yang Y, Gu JJ, Yu HY, Jin SB, Wei Z, Chen F, Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet, 2009, 18(22): 4340–4349.
[14] Wang YX, Jiang YH, Liu S, Sun XF, Gao SR. Generation of induced pluripotent stem cells from human β-thalassemia fi-broblast cells. Cell Res, 2009, 19(9): 1120–1123.
[15] Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng FY, Zhou Q. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461(7260): 86–90.
[16] Zhang DH, Jiang W, Liu M, Sui X, Yin XL, Chen S, Shi Y, Deng HK. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insu-lin-producing cells. Cell Res, 2009, 19(4): 429–438.
[17] Song ZH, Cai J, Liu YX, Zhao DX, Yong J, Duo SG, Song XJ, Guo YS, Zhao Y, Qin H, Yin
